Comparison of treatments, investigations and outcomes
| Single admitters (n=212) (%) | Readmitters (n=49) (%) | p Value | COE (n=201) (%) | Cardiology (n=36) (%) | p Value | |
|---|---|---|---|---|---|---|
| Loop Diuretics | 84.4 | 75.9 | NS* | 84.6 | 77.8 | NS* |
| ACEi/ARB | 67.9 | 58.6 | NS* | 67.1 | 52.8 | NS* |
| β Blocker | 47.2 | 53.4 | NS* | 42.8 | 63.9 | <0.05* |
| ARA | 24.5 | 36.2 | <0.05* | 31.8 | 38.9 | NS* |
| Echo | 26.9 | 17.2 | NS* | 22.4 | 33.3 | NS* |
| LVEF | 49.6 | 44.1 | <0.05† | 48.1 | 44.9 | NS† |
| Median LOS | 7 | 7 | – | 7 | 10 | – |
| Mortality | ||||||
| Inpatient | 12.3 | 16.3 | NS* | 12.9 | 0 | <0.05* |
| Median 337 days | 22.2 | 65.3 | <0.0001* | 29.4 | 8.3 | <0.01* |
*p Value calculated using 2-tailed Fisher’s exact test.
†p Value calculated using a 2-tailed unpaired Student t test.
ACEi, ACE inhibitor; ARA, aldosterone receptor antagonist; ARB, angiotensin receptor blocker; COE, care of elderly; LOS, length of stay; LVEF, left ventricular ejection fraction; NS, not significant.